Molecular imaging of cancer using PET and SPECT.
Molecular imaging allows for the study of molecular and cellular events in the living intact organism. The nuclear medicine methodologies of positron emission tomography (PET) and single photon emission computer tomography (SPECT) posses several advantages, which make them particularly suited for molecular imaging of cancer. Especially the possibility of a quick transfer of methods developed in animals to patients (translational research) is an important strength. This article will briefly discuss the newest applications and their importance and perspective in relation to the shift in paradigm in medicine towards more individualized treatment.
Kjaer
Andreas
A
Department of Clinical Physiology, Nuclear Medicine and PET Rigshospitalet and Cluster for molecular imaging, Faculty of Health Sciences, University of Copenhagen, Denmark.
D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D049268:Positron-Emission Tomography / Q000379:methods*; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*